Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Revance Therapeutics (NQ: RVNC ) 4.310 +0.070 (+1.65%) Streaming Delayed Price Updated: 4:00 PM EST, Nov 14, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Revance Therapeutics < Previous 1 2 ... 8 9 10 11 12 13 14 15 Next > REVANCE THERAPEUTICS SHAREHOLDER NOTICE November 25, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Exposures Product Safety REVANCE THERAPEUTICS SHAREHOLDER ALERT November 24, 2021 Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Revance Therapeutics To Contact Him Directly To Discuss Their Options Via NewMediaWire Exposures Product Safety REVANCE THERAPEUTICS INVESTOR ALERT November 23, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Exposures Product Safety REVANCE THERAPEUTICS INVESTOR ALERT November 20, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Exposures Product Safety Revance to Present Clinical Data on DaxibotulinumtoxinA for Injection and Hyaluronic Acid Filler Injection Technique at the 2021 American Society for Dermatologic Surgery (ASDS) Virtual Annual Meeting November 19, 2021 From Revance Therapeutics, Inc. Via Business Wire REVANCE THERAPEUTICS INVESTOR ALERT November 19, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Exposures Product Safety Revance to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference November 18, 2021 From Revance Therapeutics, Inc. Via Business Wire REVANCE ALERT: Bragar Eagel & Squire, P.C. is Investigating Revance Therapeutics, Inc. on Behalf of Revance Stockholders and Encourages Investors to Contact the Firm November 17, 2021 From Bragar Eagel & Squire, P.C. Via Business Wire INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Revance Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm November 17, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Lawsuit Exposures Financial Legal Product Safety REVANCE THERAPEUTICS INVESTOR ALERT November 16, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Exposures Product Safety REVANCE THERAPEUTICS UPDATE November 14, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Exposures Product Safety REVANCE THERAPEUTICS UPDATE November 12, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Exposures Product Safety REVANCE THERAPEUTICS UPDATE November 11, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Exposures Product Safety REVANCE THERAPEUTICS SHAREHOLDER NOTICE November 10, 2021 Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Revance Therapeutics To Contact Him Directly To Discuss Their Options Via NewMediaWire Exposures Product Safety Revance to Participate in the Stifel 2021 Virtual Healthcare Conference November 10, 2021 From Revance Therapeutics, Inc. Via Business Wire Revance Therapeutics Inc (RVNC) Q3 2021 Earnings Call Transcript November 10, 2021 RVNC earnings call for the period ending September 30, 2021. Via The Motley Fool Topics Earnings Exposures Financial REVANCE THERAPEUTICS SHAREHOLDER ALERT November 09, 2021 Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Revance Therapeutics To Contact Him Directly To Discuss Their Options Via NewMediaWire Exposures Product Safety Revance Reports Third Quarter 2021 Financial Results, Provides Corporate Update November 09, 2021 From Revance Therapeutics, Inc. Via Business Wire REVANCE THERAPEUTICS INVESTOR ALERT November 08, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Exposures Product Safety The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data November 09, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces... Via Benzinga REVANCE THERAPEUTICS SHAREHOLDER ALERT November 07, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Exposures Product Safety REVANCE THERAPEUTICS INVESTOR ALERT November 05, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Exposures Product Safety REVANCE THERAPEUTICS UPDATE November 04, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Exposures Product Safety REVANCE THERAPEUTICS SHAREHOLDER NOTICE November 03, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Exposures Product Safety INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Revance Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm November 03, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Lawsuit Exposures Financial Legal Product Safety REVANCE THERAPEUTICS SHAREHOLDER ALERT November 02, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Exposures Product Safety Revance to Release Third Quarter 2021 Financial Results on Tuesday, November 9, 2021 November 02, 2021 From Revance Therapeutics, Inc. Via Business Wire REVANCE THERAPEUTICS INVESTOR ALERT November 01, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Exposures Product Safety ONGOING INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Revance Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm November 01, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Lawsuit Exposures Financial Legal Product Safety REVANCE THERAPEUTICS SHAREHOLDER ALERT October 31, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Exposures Product Safety < Previous 1 2 ... 8 9 10 11 12 13 14 15 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
